Novo Nordisk A/S
Status: Publicly traded
Direct answer
Novo Nordisk A/S is publicly traded on NYSE under the ticker NVO.
Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business...
Can you invest in Novo Nordisk A/S?
Yes. Novo Nordisk A/S is publicly traded on NYSE under the ticker NVO.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Novo Nordisk A/S
Detailed equity research is provided by MarketSnap.